JSPR - Jasper Therapeutics, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5553
Avg. Estimate-0.15-0.15-0.65-0.54
Low estimate-0.2-0.17-0.81-0.61
High estimate-0.12-0.13-0.54-0.5
Year ago EPS-0.29-0.32-1.03-0.65
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1122
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.31-0.34-0.36-0.16
Actual EPS-0.29-0.32-0.36-0.16
Difference0.020.0200
Surprise %6.50%5.90%0.00%0.00%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.15-0.15-0.65-0.54
7 days ago-0.15-0.15-0.65-0.54
30 days ago-0.13-0.14-0.6-0.53
60 days ago-0.13-0.14-0.6-0.53
90 days ago-0.12-0.13-0.83-1.06
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days11N/A2
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesJSPRIndustrySector(s)S&P 500
Current qtr.48.30%N/AN/AN/A
Next qtr.53.10%N/AN/AN/A
Current year36.90%N/AN/AN/A
Next year16.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A